← Open Payments lookup

REBECCA NOLL: Open Payments

NPI 1720752173 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$907 in 37 payments from 12 companies in 2025. Trend: 2023 $1,569 · 2024 $1,638 · 2025 $907

Food & beverage: $907
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$139
Alkermes, Inc.6$137
ABBVIE INC.4$102
Neurocrine BioSciences, Inc.3$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$84
Axsome Therapeutics, Inc.4$78
E.R. Squibb & Sons, L.L.C.3$75
Otsuka America Pharmaceutical, Inc.2$49
Lundbeck LLC2$49
Almatica Pharma LLC2$45

Products named: UZEDY, VRAYLAR, REXULTI, INGREZZA, ARISTADA, CAPLYTA, Auvelity, COBENFY.

Industry payments across MD — which companies pay providers there.